Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy.

BIBLIOGRAPHIC SOURCE(S)

  • Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy. Los Angeles (CA): Society of American Gastrointestinal and Endoscopic Surgeons (SAGES); 2007 Sep. 25 p. [178 references]

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). SAGES guidelines for laparoscopic surgery during pregnancy. Santa Monica (CA): Society of American Gastrointestinal Endoscopic Surgeons (SAGES); 2000 Oct. 4 p. [31 references]

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Levels of evidence (I–III) and recommendation grades (A–C) are defined at the end of the "Major Recommendations" field.

Diagnosis and Workup

Imaging Techniques

Ultrasound

Guideline 1: Ultrasonographic imaging during pregnancy is safe and useful in identifying the etiology of acute abdominal pain in the pregnant patient (Level II, Grade A).

Risk of Ionizing Radiation

Guideline 2: Expeditious and accurate diagnosis should take precedence over concerns for ionizing radiation. Radiation dosage should be limited to 5-10 rads in the first 25 weeks of pregnancy (Level III, Grade B).

Computed Tomography (CT)

Guideline 3: Contemporary multi-detector CT protocols deliver a radiation dose to the fetus below detrimental levels and may be considered as an appropriate test during pregnancy depending on the clinical situation (Level III, Grade B).

Magnetic Resonance (MR) Imaging

Guideline 4: MR Imaging can be performed at any stage of pregnancy without the use of intravenous Gadolinium (Level III, Grade B).

Nuclear Medicine

Guideline 5: Nuclear Medicine administration of radio nucleotides can generally be accomplished at fetal radiation levels of exposure that are well below any known detrimental levels (Level III, Grade C).

Cholangiography

Guideline 6: Intra-operative and endoscopic cholangiography exposes the mother and fetus to minimal radiation and may be used selectively during pregnancy. The lower abdomen should be shielded when performing cholangiography during pregnancy to decrease the radiation exposure to the fetus (Level III, Grade B).

Surgical Techniques

Guideline 7: Diagnostic laparoscopy is safe and effective when used selectively in the workup and treatment of acute abdominal processes in pregnancy (Level II, Grade B).

Patient Selection

Pre-operative Decision Making

Guideline 8: Laparoscopic treatment of acute abdominal processes has the same indications in pregnant and non-pregnant patients (Level II, Grade B).

Laparoscopy and Trimester of Pregnancy

Guideline 9: Laparoscopy can be safely performed during any trimester of pregnancy (Level II, Grade B).

Treatment

Patient Positioning

Guideline 10: Gravid patients should be placed in the left lateral recumbent position to minimize compression of the vena cava and the aorta (Level II, Grade B).

Initial Port Placement

Guideline 11: Initial access can be safely accomplished with open (Hassan), Verres needle, or optical trocar technique if the location is adjusted according to fundal height, previous incisions, and experience of the surgeon (Level III, Grade B).

Insufflation Pressure

Guideline 12: Carbon dioxide (CO2) insufflation of 10-15 mm Hg can be safely used for laparoscopy in the pregnant patient. Intra-abdominal pressure should be sufficient to allow for adequate visualization (Level III, Grade C).

Intra-operative CO2 Monitoring

Guideline 13: Intra-operative CO2 monitoring by capnography should be used during laparoscopy in the pregnant patient (Level III, Grade C).

Venous Thromboembolic (VTE) Prophylaxis

Guideline 14: Intra-operative and post-operative pneumatic compression devices and early post-operative ambulation are recommended prophylaxis for deep venous thrombosis in the gravid patient (Level III, Grade C).

Gallbladder Disease

Guideline 15: Laparoscopic cholecystectomy is the treatment of choice in the pregnant patient with gallbladder disease regardless of trimester (Level II, Grade B).

Choledocholithiasis

Guideline 16: Choledocholithiasis during pregnancy may be managed with preoperative endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy followed by laparoscopic cholecystectomy, intra-operative laparoscopic transcystic or choledochotomy common bile duct exploration, or post-operative ERCP depending on local resources and clinical scenario (Level III, Grade C).

Laparoscopic Appendectomy

Guideline 17: Laparoscopic appendectomy may be performed safely in pregnant patients with suspicion of appendicitis (Level II, Grade B).

Solid Organ Resection

Guideline 18: Laparoscopic adrenalectomy, nephrectomy and splenectomy are safe procedures in pregnant patients when indicated and standard precautions are taken (Level III, Grade C).

Adnexal Masses

Guideline 19: Laparoscopy is safe and effective treatment in gravid patients with symptomatic cystic masses. Observation is acceptable for all other cystic lesions provided ultrasound is non-worrisome for malignancy and tumor markers are normal. Initial observation is warranted for most cystic lesions <6 cm in size (Level III, Grade C).

Adnexal Torsion

Guideline 20: Laparoscopy is recommended for both diagnosis and treatment of adnexal torsion unless clinical severity warrants laparotomy (Level III, Grade C).

Peri-operative Care

Fetal Heart Monitoring

Guideline 21: Fetal heart monitoring should occur pre- and postoperatively in the setting of urgent abdominal surgery during pregnancy (Level III, Grade B).

Obstetrical Consultation

Guideline 22: Obstetric consultation can be obtained pre- and/or postoperatively based on the acuteness of the patient's disease and availability (Level III, Grade B).

Tocolytics

Guideline 23: Tocolytics should not be used prophylactically, but should be considered peri-operatively when signs of preterm labor are present in coordination with obstetric consultation (Level I, Grade A).

Definitions:

Levels of Evidence

Level I - Evidence from properly conducted randomized, controlled trials

Level II - Evidence from controlled trials without randomization

Or

Cohort or case-control studies

Or

Multiple time series, dramatic uncontrolled experiments

Level III - Descriptive case series, opinions of expert panels

Recommendation Grades

Grade A - Based on high-level (level I or II), well-performed studies with uniform interpretation and conclusions by the expert panel

Grade B - Based on high-level, well-performed studies with varying interpretation and conclusions by the expert panel

Grade C - Based on lower level evidence (level II or less) with inconsistent findings and/or varying interpretations or conclusions by the expert panel

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is identified and graded for each recommendation (see "Major Recommendations").

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy. Los Angeles (CA): Society of American Gastrointestinal and Endoscopic Surgeons (SAGES); 2007 Sep. 25 p. [178 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1996 Feb (revised 2007 Sep)

GUIDELINE DEVELOPER(S)

Society of American Gastrointestinal and Endoscopic Surgeons - Medical Specialty Society

SOURCE(S) OF FUNDING

Society of American Gastrointestinal Endoscopic Surgeons (SAGES)

GUIDELINE COMMITTEE

Guidelines Committee

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Not stated

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Members of the Society of American Gastrointestinal and Endoscopic Surgeons disclose potential conflicts of interest and pertinent financial relationships prior to serving as faculty for SAGES-sponsored educational events, delivering presentations at scientific meetings, etc. Additionally, members of SAGES Committees disclose their potential conflicts of interest and pertinent financial relationships annually as a condition of committee membership.

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). SAGES guidelines for laparoscopic surgery during pregnancy. Santa Monica (CA): Society of American Gastrointestinal Endoscopic Surgeons (SAGES); 2000 Oct. 4 p. [31 references]

GUIDELINE AVAILABILITY

Electronic copies: Available from the Society of American Gastrointestinal Endoscopic Surgeons (SAGES) Web site.

Print copies: Available from the Society American Gastrointestinal Endoscopic Surgeons (SAGES), 11300 W. Olympic Blvd., Suite 600, Los Angeles, CA 90064; Web site: www.sages.org.

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI Institute on December 11, 2007. The information was verified by the guideline developer on December 19, 2007.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo